Two former medical device company executives have called for the Supreme Court to review their convictions on charges related to their alleged off-label promotion of a device (Facteau v. United States, No. 23-1016 (U.S.)). In their petition for a writ of certiorari, the two officials present a full-throated condemnation of what they see as the unconstitutionality of the FDA’s... Read More